Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension I: Introduction01:28

Hypertension I: Introduction

119
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
119
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

93
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
93
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

68
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
68
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

132
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
132
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

3.3K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.3K
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

61
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
61

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cohort profile: Swiss personalized health network cohort consortium.

European journal of epidemiology·2026
Same author

Biochemical and clinical remission after adrenalectomy in patients with primary aldosteronism: a retrospective two-center study.

Gland surgery·2026
Same author

[Cardiorenal syndrome : what's new in 2026].

Revue medicale suisse·2026
Same author

Long-term citrate treatment in high-risk kidney stone formers is not associated with metabolic adverse effects.

Clinical kidney journal·2026
Same author

Associations of 24-h urinary excretion of heavy metals and trace elements with estimated glomerular filtration rate and chronic kidney disease.

Scientific reports·2026
Same author

Characterization of residual kidney function in chronic hemodialysis patients using plasma metabolomics.

Scientific reports·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

[Erythema multiforme : target deciphering].

Revue medicale suisse·2026
See all related articles

Related Experiment Video

Updated: Oct 4, 2025

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

3.5K

[Hypertension: novelties 2021].

Grégoire Wuerzner1, Belen Ponte2, Antoinette Pechère-Bertschi2

  • 1Service de néphrologie et hypertension, Centre hospitalier universitaire vaudois, 1011 Lausanne.

Revue Medicale Suisse
|February 2, 2022
PubMed
Summary
This summary is machine-generated.

High blood pressure affects over 1.2 billion globally, with many unaware and few reaching treatment targets. This review examines adherence, intensive treatment in older adults, and interventions in pregnancy and diet.

More Related Videos

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

873
Assessing Murine Resistance Artery Function Using Pressure Myography
07:25

Assessing Murine Resistance Artery Function Using Pressure Myography

Published on: June 7, 2013

22.5K

Related Experiment Videos

Last Updated: Oct 4, 2025

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

3.5K
Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

873
Assessing Murine Resistance Artery Function Using Pressure Myography
07:25

Assessing Murine Resistance Artery Function Using Pressure Myography

Published on: June 7, 2013

22.5K

Area of Science:

  • Cardiology
  • Epidemiology
  • Public Health

Background:

  • Arterial hypertension is a global health crisis affecting over 1.2 billion individuals.
  • A significant portion of hypertensive patients remain undiagnosed or inadequately treated, highlighting a critical gap in care.
  • Poorly controlled hypertension poses substantial risks for cardiovascular events, particularly in vulnerable populations.

Purpose of the Study:

  • To review recent epidemiological findings on the prevalence and management of arterial hypertension.
  • To discuss the impact of treatment adherence and intensity on cardiovascular outcomes in diverse patient groups.
  • To present novel therapeutic strategies, including hemodynamic-guided treatment in pre-eclampsia and the role of potassium supplementation.

Main Methods:

  • Analysis of recent epidemiological studies on hypertension prevalence and treatment efficacy.
  • Review of clinical data on adherence, intensive treatment in the elderly, and pre-eclampsia management.
  • Examination of research on dietary interventions, specifically potassium supplementation in table salt.

Main Results:

  • Over 1.2 billion people worldwide have high blood pressure; half are unaware, and only 25% achieve target control.
  • Non-adherence in young patients significantly increases cardiovascular event risk.
  • Intensive treatment in patients over 60 shows potential benefits, while hemodynamic-guided adjustments in pregnant women require further study.
  • Potassium supplementation in table salt may influence cardiovascular events.

Conclusions:

  • Urgent strategies are needed to improve hypertension awareness, adherence, and treatment target achievement globally.
  • Personalized treatment approaches, considering age and specific conditions like pre-eclampsia, are crucial.
  • Further research into dietary interventions, such as potassium supplementation, may offer new avenues for cardiovascular risk reduction.